Explore challenges and top-of-mind concerns of business leaders today.
To thrive in today's marketplace, one must never stop learning. Here we offer our latest thinking and top-of-mind resources.
Our multi-disciplinary approach and deep, practical industry knowledge, skills and capabilities help our clients meet challenges and respond to opportunities.
Connect with us via webcast, podcast, or in person at industry events.
IFRS Institute Advisory Leader, KPMG US
Partner, DPP, KPMG US
Partner, Audit, KPMG US
Partner in Charge, US Germany Corridor, KPMG US
KPMG’s latest update on current IFRS issues: IFRS 16 vs. ASC 842, insurance, IFRS 9 impairment model, going public in Canada and R&D costs.
The IFRS and US GAAP requirements for lessees’ Day Two accounting will create significant implementation issues.
The new standard will require fundamental accounting changes to how insurance contracts are measured and accounted for. It also differs significantly from US GAAP.
Implementing IFRS 9, and in particular its new impairment model, is the focus of many global banks, insurance companies and other financial institutions in 2017, in the run-up to the effective date.
This article explores some of the financial reporting requirements for a company deciding whether to list on a Canadian stock market.
Under US GAAP, R&D costs within the scope of ASC 730 are expensed as incurred.
CPE seminars and customized training